OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

TechCrunch AI · 1 day ago

Miles Wang, an OpenAI researcher specializing in AI for scientific discovery, is leaving to start a drug discovery startup with several other OpenAI researchers. The new company is in funding discussions with Lightspeed to raise $200 million at a $2 billion valuation. The startup would focus on developing AI models to identify new uses for existing drugs, potentially reducing time to market compared to discovering entirely new treatments.